Novotech Archives | Be Korea-savvy

Home / Posts tagged Novotech

Novotech Appoints Commercial and Clinical Life Sciences Specialist to Head Up Global Drug Development Consulting Team

BOSTON, May 2 (Korea Bizwire) – Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has appointed Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC). Novotech’s Chief Medical Officer Dr. Judith Ng-Cashin stated: “We welcome Scott to [...]

Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs

BOSTON, Apr. 10 (Korea Bizwire) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an expert report, Acute Myeloid Leukaemia – Global Clinical Trial Landscape, offering critical data-backed analysis of the latest developments in Acute Myeloid [...]

Novotech Publishes Analyst Report on Cystic Fibrosis Clinical Trial Landscape to Inform Biotech Research Planning

BOSTON, Apr. 10 (Korea Bizwire) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report entitled Cystic Fibrosis – Global Clinical Trial Landscape. The report presents a data-backed review of the Cystic Fibrosis [...]

Novotech Publishes Precision Oncology Landscape Whitepaper Identifying Current Trends and Opportunities in Targeted Therapies

BOSTON, Mar. 12 (Korea Bizwire) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an insightful whitepaper, Precision Oncology – Global Clinical Trial Landscape, providing the latest research insights for cancer treatments. The Novotech research analyst [...]

Novotech Publishes Candidiasis and Rheumatoid Arthritis Clinical Trial Landscape Reports to Support Biotech Research Planning

BOSTON, Feb. 11, 2024 (Korea Bizwire) – Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released today two industry leading reports on the Candidiasis and Rheumatoid Arthritis clinical trial landscapes. Importantly the reports also include a [...]

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions

SAN FRANCISCO, Jan. 08, 2024 (Korea Bizwire) – Novotech, a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, announced today that it will have the largest ever presence at the J.P.Morgan Healthcare Conference in San Francisco, CA, USA, January 8-11, [...]

New Novotech Report Finds 1,000 HIV Clinical Trials Globally

BOSTON, Dec. 28 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people. The Novotech research analyst team provides these expert reports on a monthly basis, completely free of charge. These [...]

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global Biotech Clinical Trials in 2024

HONG KONG, Nov. 26 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, will be presenting at the Clinical Research Governance (CRGo) World Conference & International Clinical Trial Center Network (ICN) Symposium 2023 in Hong Kong this month. Michael Stibilj, Novotech’s Chief Operating Officer, will discuss the potential, challenges, and practical applications of [...]

Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials

SHANGHAI, China, Nov. 07, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, opens the ChinaTrials 15 conference in Shanghai, China with a message to China biotechs about the benefits of conducting simultaneous China, US and Australia trials to accelerate drug development. (November 8-10, 2023) Novotech is commencing this significant summit [...]

Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide

BOSTON, Nov. 06 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest 2023 global clinical trial environment whitepaper focused on infectious diseases. The Novotech research analyst team offers these expert reports monthly at no cost. This helps to contribute to the advancement of knowledge of the clinical [...]